Hormonal Support Supplements: Evidence and Comparison

What does this guide compare?

Steroid precursors and other metabolism-related ingredients do not share one indication.

This collection compares products discussed around one topic. It is not a protocol to take in full. Links to individual profiles appear after the article.

Which products are compared?

How do their roles differ?

DHEA and pregnenolone are steroid precursors; indole-3-carbinol and calcium-D-glucarate are discussed in relation to other metabolic pathways. These ingredients do not share one hormone-balancing mechanism. A change in a laboratory hormone value is distinct from improvement in a diagnosed condition. [1][2][5][6]

What does the research show?

DHEA: higher hormone levels did not translate into broad anti-aging benefits

Nair and colleagues randomized 92 older men and 60 older women with low DHEAS in the methods report; the abstract describes 87 men and 57 women in its reported study groups. The two-year study used DHEA 75 mg/day in men and 50 mg/day in women, versus matching placebo; a separate male arm received a testosterone patch. These are research exposures, not a recommended supplement schedule. DHEAS increased, but DHEA did not meaningfully improve physical performance, insulin sensitivity or quality of life. Small changes at selected bone-density sites did not establish fracture prevention. This population and protocol cannot answer every diagnosed endocrine condition. [5]

Pregnenolone: a short pain trial answers a different question

Naylor and colleagues randomized 100 US military veterans with chronic low back pain; 94 were included in the reported baseline characteristics, with most participants male. After a one-week placebo lead-in, the active group took 50 mg twice daily for one week, 150 mg twice daily for one week, then 250 mg twice daily for two weeks; a four-day taper followed. The adjusted between-group difference in the pain diary was 0.56 points in favor of pregnenolone on a 0–10 scale after four weeks. This short adjunctive trial was not designed to determine the optimal dose, long-term safety, or treatment of a hormone deficiency. It was VA-funded, and the disclosure section includes pending investigator patent applications. [6]

I3C and calcium-D-glucarate: keep mechanisms separate from clinical outcomes

MSK describes early I3C clinical studies and mixed preclinical findings. I3C, its metabolite DIM, a mixed supplement and a diet rich in cruciferous vegetables are different exposures. A change in estrogen metabolites is not proof of cancer prevention. For calcium-D-glucarate, the proposed elimination pathway and animal findings do not establish a human treatment for estrogen excess or cancer. Neither reference validates taking all four products together. [1][2]

Which overlaps and risks matter?

Cautions and interactions

Hormone-sensitive conditions, pregnancy, concurrent hormone therapy and product adulteration change the risk assessment. Self-directed precursor combinations can make symptoms and laboratory values harder to interpret. Supplements are not interchangeable with clinician-managed HRT or TRT. [1][2][5][6]

A complete product list includes prescription medicines, nonprescription products and supplements. Combination formulas can conceal duplicate ingredients. Timing and spacing from a medicine should follow its labeling and pharmacist guidance; this collection does not supply a universal timetable.

I3C may induce CYP1A2 in laboratory studies, but the clinical interaction magnitude remains uncertain. A pharmacist should review concurrent medicines rather than assuming this is harmless or a proven interaction at every dose. [1]

Regulatory status

In the United States, FDA does not approve dietary supplements for safety and effectiveness before marketing. In Canada, a natural health product requires a product licence before sale; its NPN or DIN-HM must match the finished product. An ingredient name or inclusion in this collection does not establish that every product or claim is authorized. Authorization also does not validate the complete combination. [3], [4]

What should be recorded and how should changes be interpreted?

Doserly brings dose logs, symptoms and routine changes together. For this collection, useful observations include cycle or symptom timing, all hormonal medicines, product changes and clinician-interpreted laboratory results.

• Doses and adherence: record the formulation, amount actually taken, timing and missed doses so observations have context.
• Potential benefits and tolerability: compare consistent symptoms or measurements over time alongside sleep, food and activity changes. Personal trends help evaluate the experience without proving causal efficacy.
• Product list: maintain the full product list for review with a pharmacist or clinician.
• AI monthly reports: summarize recorded doses, symptoms and trends to prepare for a discussion. Reports depend on the data entered and are not a diagnosis or an instruction to change treatment.

Explore the topic further

Common questions

Is DHEA an alternative to prescribed TRT or HRT?

No. A steroid precursor is not interchangeable with a prescribed hormone, its indication or its monitoring. Raising a hormone measurement did not produce broad functional benefits in the cited older-adult trial. [5]

Does the pregnenolone trial support taking it for fatigue or menopause?

No. It studied chronic low back pain in mostly male military veterans for four active-treatment weeks. The measured pain result does not establish those other uses. [6]

Can an estrogen metabolite test prove that an I3C or glucarate supplement is working?

A laboratory change can show an effect on a pathway. It does not by itself demonstrate better symptoms, cancer prevention, or long-term safety. [1][2]

What is useful to track alongside clinician-directed care?

The exact product and formulation, changes in all hormonal medicines, symptom or cycle dates, and the timing of clinician-ordered tests. Doserly can organize those records; it does not interpret them as a diagnosis or choose hormone doses.

Glossary

Terms for interpreting the comparisons.

Formulation

The exact preparation, including its ingredients, their forms and labeled amounts.

Study population

The people included in a study; their characteristics limit where its result applies.

Comparator

The placebo, treatment or condition used as the comparison.

Measured outcome

What the study evaluates, such as a symptom, laboratory result or clinical event.

Overlap

The same ingredient appearing in more than one product used together.

How was this guide researched?

Sources and limits

This AI-assisted educational guide compares the cited public references. Findings remain tied to the ingredients, preparations and populations studied. It is not a systematic review or independent medical peer review. Doserly develops a commercial tracking app. Illustrations explain concepts; app screens show example data. Report a correction with its source to Doserly support.

Explore the sources